HNF1B maturity-onset diabetes of the young (MODY) (previously named MODY5) is a syndrome due to heterozygous molecular anomalies of the hepatocyte nuclear factor (HNF)1B that may associate diabetes, morphological and functional abnormalities of the kidneys and of the pancreas, liver test anomalies, and genital tract malformations (1,2). MODY5 is due to HNF1B point mutations in half the cases, and is associated to a chromosome 17q12 deletion encompassing the HNF1B gene in the other half (3,4).

Pectus excavatum (PE) is the most frequent anterior chest wall deformity. It has been described as an isolated anomaly or as part of many genetic syndromes, including monogenic diseases and chromosome aberrations (reviewed in 5). So far, PE has not been described in the context of HNF1B anomalies.

Following the observation of a patient with typical MODY5 and PE (case 1, Table 1), we have reviewed the files of 59 adult patients (29 males, 30 females) with an HNF1B molecular anomaly (31 mutations, 28 deletions). In six patients, the presence of PE was mentioned by the referring physician (including a father and his son, cases 1 and 2), and was confirmed by two of us. No patient had a severe form with respiratory or other clinical consequences. The main characteristics of the six patients are shown in Table 1. Diabetes, present in five of six patients, was revealed by acute onset in three patients. Basal and glucagon-stimulated C-peptide concentrations were low in the five tested patients. In the sixth patient, follow-up fasting blood glucose and HbA1c were 5.7 mmol/L and 34 mmol/mol, respectively. Renal disease was present in all patients. Liver tests abnormalities were observed in five of six patients, with fluctuating increased levels of transaminases and/or γ-glutamyl transferase. Fecal elastase concentration was decreased in three of five tested patients.

Table 1

Main characteristics of six patients with HNF1B molecular anomaly and PE

Main characteristics of six patients with HNF1B molecular anomaly and PE
Main characteristics of six patients with HNF1B molecular anomaly and PE

In this series of MODY5 patients, the minimal prevalence of PE was 10% (8% in probands, and 21% in male patients). Since chest wall morphology was not systematically described in the files, the actual frequency could be higher. Nevertheless, the observed prevalence is by far much higher than that expected in the general population, which has been reported to be 1:400, with a male-to-female ratio of 4:1 (5).

Among the six patients with MODY5 and PE, an HNF1B point mutation was found in four patients (three probands) and an HNF1B deletion in two patients (Table 1).

These results suggest that molecular anomalies of the HNF1B gene may be involved in the development of PE, and expand the clinical spectrum of the HNF1B-associated disease. The presence of PE may strengthen the suspicion of MODY5 in some patients with uncommon forms of diabetes.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. D.D.-L. and J.T. researched data and wrote the manuscript. C.B.-C. and J.-F.S. researched data and contributed to discussion. J.T. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

1.
Bellanné-Chantelot
C
,
Chauveau
D
,
Gautier
JF
, et al
.
Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations
.
Ann Intern Med
2004
;
140
:
510
517
2.
Chen
YZ
,
Gao
Q
,
Zhao
XZ
, et al
.
Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5
.
Chin Med J (Engl)
2010
;
123
:
3326
3333
3.
Bellanné-Chantelot
C
,
Clauin
S
,
Chauveau
D
, et al
.
Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5
.
Diabetes
2005
;
54
:
3126
3132
4.
Ulinski
T
,
Lescure
S
,
Beaufils
S
, et al
.
Renal phenotypes related to hepatocyte nuclear factor-1β (TCF2) mutations in a pediatric cohort
.
J Am Soc Nephrol
2006
;
17
:
497
503
5.
Kotzot
D
,
Schwabegger
AH
.
Etiology of chest wall deformities—a genetic review for the treating physician
.
J Pediatr Surg
2009
;
44
:
2004
2011
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.